208
Views
5
CrossRef citations to date
0
Altmetric
Polycystic Ovary Syndrome

Effect of letrozole for ovulation induction combined with intrauterine insemination on women with polycystic ovary syndrome

, , &
Pages 860-863 | Received 24 Nov 2019, Accepted 16 Mar 2020, Published online: 03 Apr 2020

References

  • Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016;33(1):15–28.
  • Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119–129.
  • Patel SM, Nestler JE. Fertility in polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2006;35(1):137–155.
  • Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo). 2015;70(11):765–769.
  • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
  • Stefano P. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015;100(5):1742–1747.
  • Casper RF, Mitwally MFM. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91(3):760–771.
  • Klement AH, Casper RF. The use of aromatase inhibitor for ovulation induction. Curr Opin Obstet Gynecol. 2015;27(3):206–209.
  • Misso ML, Wong JLA, Teede HJ, et al. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(3):301–312.
  • Ahmed Walid AM, Elhadi Farag MA. Impact of letrozole on ultrasonographic markers of endometrial receptivity in polycystic ovary syndrome women with poor endometrial response to clomiphene citrate despite adequate ovulation. Middle East Fertil Soc J. 2015;20(3):182–187.
  • Xi W, Liu S, Mao H, et al. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study. Drug Des Devel Ther. 2015;9:6001–6008.
  • Fica S, Albu A, Constantin M, et al. Insulin resistance and fertility in polycystic ovary syndrome. J Med Life. 2008;1(4):415–422.
  • Bonova E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care. 2000;23:57–63.
  • Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–2410.
  • Le MT, Le VH, Nguyen TPL, et al. Metabolic disorder in infertility patients with polycystic ovarian syndrome. Med Pharm J. 2017;7(3):7–13.
  • World Health Organisation (WHO), International Association for the Study of Obesity, and International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Limited on behalf of the Steering Committee; 2000.
  • Roy KK, Baruah J, Singla S, et al. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci. 2012;5(1):20–25.
  • Atay V, Cam C, Muhcu M, et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006;34(1):73–76.
  • Dehbashi S, Dehbashi S, Kazerooni T, et al. Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iran J Med Sci. 2009;34(1):23–28.
  • Lin TC, Yen JM, Gong KB, et al. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med Genet. 2006;7:36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.